[1] [2] Symptoms that have been described include: Injection site reactions : redness, swelling, itching, or mild bruising at the site of subcutaneous administration consistent with class effects seen with semaglutide and tirzepatide (see eMC SmPCs for Wegovy, Ozempic, and Mounjaro for comparator data) Pruritus or urticaria : patchy or widespread skin itching or redness, which may reflect a hypersensitivity response again consistent with known class effects of GLP-1-based therapies [17] Generalised skin sensitivity : heightened sensitivity to touch, temperature, or pressure beyond the injection site
Waiting for 30-year thyroid safety data while allowing obesity-related damage to accumulate seems like poor risk management to me
cell type TAM: F (1,19) = 1.338, p = 0.2618
Pre liposuction peptides like AOD-9604, CJC-1295, Ipamorelin, Tesamorelin, and Semaglutide provide targeted fat loss advantages for body composition